Harmony Biosciences Holdings Inc (NASDAQ: HRMY) is 7.65% higher on its value in year-to-date trading and has touched a low of $18.61 and a high of $40.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HRMY stock was last observed hovering at around $35.57 in the last trading session, with the day’s loss setting it -0.8%.
Currently trading at $34.77, the stock is -8.60% and -3.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.74 million and changing -2.25% at the moment leaves the stock 6.94% off its SMA200. HRMY registered 7.38% gain for a year compared to 6-month gain of 11.34%. The firm has a 50-day simple moving average (SMA 50) of $36.0103 and a 200-day simple moving average (SMA200) of $32.51985.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -3.52% loss in the last 1 month and extending the period to 3 months gives it a 9.41%, and is -12.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.79% over the week and 4.21% over the month.
Harmony Biosciences Holdings Inc (HRMY) has around 246 employees, a market worth around $1.98B and $656.11M in sales. Current P/E ratio is 17.80 and Fwd P/E is 9.39. Profit margin for the company is 17.53%. Distance from 52-week low is 86.82% and -14.36% from its 52-week high. The company has generated returns on investments over the last 12 months (16.18%).
The EPS is expected to grow by 5.32% this year
319.0 institutions hold shares in Harmony Biosciences Holdings Inc (HRMY), with institutional investors hold 116.69% of the company’s shares. The shares outstanding are 56.77M, and float is at 30.70M with Short Float at 27.40%. Institutions hold 93.64% of the Float.
The top institutional shareholder in the company is VALOR MANAGEMENT LLC with over 11.22 million shares valued at $338.45 million. The investor’s holdings represent 19.7601 of the HRMY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.84 million shares valued at $176.05 million to account for 10.2785 of the shares outstanding. The other top investors are FMR LLC which holds 5.24 million shares representing 9.2263 and valued at over $158.03 million, while VANGUARD GROUP INC holds 6.1992 of the shares totaling 3.52 million with a market value of $106.18 million.
Harmony Biosciences Holdings Inc (HRMY) Insider Activity
Harmony Biosciences Holdings Inc disclosed in a document filed with the SEC on Oct 01 ’24 that Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) sold a total of 400 shares of the company’s common stock. The trade occurred on Oct 01 ’24 and was made at $40.19 per share for $16077.0. Following the transaction, the insider now directly holds 0.0 shares of the HRMY stock.
Still, SEC filings show that on Oct 01 ’24, JEFFREY G DIERKS (Officer) Proposed Sale 21,796 shares at an average price of $40.00 for $0.87 million. The insider now directly holds shares of Harmony Biosciences Holdings Inc (HRMY).
